Pharma Contract Manufacturing and Packaging Market to Surpass USD 214.6 Billion by 2034

The global pharma contract manufacturing (CMO) and contract packaging (CPO) market is expected to grow at a CAGR of 8.1% from 2025 to 2034, powered by biologics production, global supply chain partnerships, and rising demand for flexible, high-quality pharmaceutical services.

Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/48113

Introduction
Pune, India - November 2025 - According to a new report by Exactitude Consultancy, the Pharma Contract Manufacturing (CMO) and Contract Packaging (CPO) Market is poised to grow from USD 98.7 billion in 2024 to approximately USD 214.6 billion by 2034, expanding at a CAGR of 8.1% during 2025-2034. Increasing drug complexity, regulatory stringency, and cost pressures are prompting pharmaceutical companies to outsource manufacturing and packaging functions to specialized global partners.

Key Takeaways
• Market Size 2024: USD 98.7 Billion
• Forecast 2034: USD 214.6 Billion
• CAGR (2025-2034): 8.1%
• Primary Drivers: Expansion of biologics, cost optimization, quality compliance, and outsourcing flexibility
• Leading Players: Lonza Group, Catalent Inc., Recipharm AB, Thermo Fisher Scientific, Jubilant Pharmova, Piramal Pharma Solutions, Siegfried Holding AG, Vetter Pharma, and Sharp Packaging

Market Story
The pharmaceutical landscape is rapidly evolving toward strategic outsourcing as companies focus on innovation and time-to-market efficiency. Contract manufacturing organizations (CMOs) and contract packaging organizations (CPOs) have become vital partners in the value chain, offering scalable production, regulatory expertise, and cutting-edge facilities.

Biopharmaceuticals and personalized medicines are reshaping production dynamics, necessitating specialized formulations, cold chain handling, and serialization capabilities. Meanwhile, the global rise in generic drug production and increased vaccine manufacturing post-COVID-19 have boosted the need for flexible contract services.

Additionally, regulatory compliance and cost control remain top priorities. CMOs and CPOs that combine automation, traceability, and end-to-end logistics solutions are best positioned to capture long-term partnerships with leading pharmaceutical and biotech firms.

Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/48113

Segmentation Overview
By Service Type:
• Pharma Contract Manufacturing (CMO):
o Active Pharmaceutical Ingredient (API) Manufacturing
o Finished Dosage Form (FDF) Manufacturing
o Secondary Processing
• Pharma Contract Packaging (CPO):
o Primary Packaging (Blister Packs, Bottles, Vials)
o Secondary Packaging (Cartons, Labels, Inserts)
o Serialization and Logistics

By Drug Type:
• Small Molecules
• Biologics and Biosimilars
• Vaccines

By End User:
• Pharmaceutical Companies
• Biotech Firms
• Generic Drug Manufacturers
By Region:
• North America: Largest share, driven by advanced biologics and regulatory frameworks.
• Europe: Growth supported by sustainability and GMP-compliant facilities.
• Asia-Pacific: Fastest growth due to cost advantages and expanding pharma infrastructure in India and China.
• Latin America & Middle East: Emerging as cost-effective regional packaging hubs.

Explore Full Report here:
https://exactitudeconsultancy.com/reports/48113/pharma-contract-manufacturing-cmo-and-pharma-contract-packaging-cpo-market

Recent Developments
• Catalent Inc. expanded its biologics production site in Anagni, Italy, to meet EU sterile filling demand.
• Lonza Group launched new bioconjugation manufacturing suites for antibody-drug conjugates (ADCs).
• Recipharm AB announced a sustainability initiative to reduce emissions across its European facilities.
• Thermo Fisher Scientific enhanced its CDMO network with expanded fill-finish capabilities in the U.S. and Asia.
• Jubilant Pharmova opened a new sterile injectables plant in India to serve global clients.

Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=48113

Expert Quote
"Pharmaceutical outsourcing is no longer a tactical move - it's a strategic growth model," said Irfan Tamboli, Business Development Executive at Exactitude Consultancy.
"Our research highlights how global CMOs and CPOs are evolving from service providers to innovation partners, enabling faster development, sustainable production, and global supply reliability."

Market Drivers
1. Rise in Biopharmaceuticals: Growing demand for biologics, biosimilars, and cell therapies boosts outsourcing needs.
2. Globalization of Pharma Supply Chains: Strategic partnerships optimize capacity and cost efficiency.
3. Regulatory Complexity: CMOs/CPOs provide GMP-certified, compliance-ready infrastructure.
4. Sustainability & Digitization: Green packaging and digital traceability enhance competitive positioning.
5. Cost Reduction Pressure: Outsourcing reduces CAPEX burden and accelerates market entry for drug makers.

Forecast & Future Outlook
From 2025 to 2034, the global pharma CMO and CPO market will experience significant consolidation and digital transformation. Data-driven quality systems, single-use bioprocessing, and AI-enabled manufacturing will redefine operational standards.
Asia-Pacific is projected to lead in production scale, while North America and Europe will retain technological dominance through innovation partnerships and regulatory strength.

By 2034, CMOs and CPOs will serve as fully integrated pharma partners, managing end-to-end product life cycles - from molecule to market.

This report is also available in the following languages : Japanese (医薬品受託製造(CMO)および医薬品受託包装(CPO)市場), Korean (제약 계약 제조(CMO) 및 제약 계약 포장(CPO) 시장), Chinese (医药合同生产(CMO)和医药合同包装(CPO)市场), French (Marché de la fabrication à façon (CMO) et du conditionnement à façon (CPO) pharmaceutiques), German (Markt für pharmazeutische Auftragsfertigung (CMO) und pharmazeutische Auftragsverpackung (CPO)), and Italian (Mercato della produzione farmaceutica su contratto (CMO) e del confezionamento farmaceutico su contratto (CPO)), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/48113

Our More Reports:

Phycocyanin Market
https://exactitudeconsultancy.com/reports/3388/phycocyanin-market

eClinical Solutions Market
https://exactitudeconsultancy.com/reports/7898/eclinical-solutions-market

Drug Safety and Pharmacovigilance Software Market
https://exactitudeconsultancy.com/reports/8058/drug-safety-and-pharmacovigilance-software-market

Biosimulation Market
https://exactitudeconsultancy.com/reports/11859/biosimulation-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.